Kolesar, Jill M.

A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs

Shin, H.-C., Alani, A. W. G., Cho, H., Bae, Y., Kolesar, J. M., & Kwon, G. S. (2011) · Molecular Pharmaceutics

Nanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems

Cited by 126

Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin

Shin, H.-C., Cho, H., Lai, T. C., Kozak, K. R., Kolesar, J. M., & Kwon, G. S. (2012) · Journal of Controlled Release

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 53

A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer

Deming, D. A., Cavalcante, L. L., Lubner, S. J., Mulkerin, D. L., LoConte, N. K., Eickhoff, J. C., Kolesar, J. M., Fioravanti, S., Greten, T. F., Compton, K., et al. (2016) · Investigational New Drugs

Colorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways

Cited by 52

Exemestane for primary prevention of breast cancer in postmenopausal women

Zhang, Y., Simondsen, K., & Kolesar, J. M. (2012) · American Journal of Health-System Pharmacy

Estrogen and related hormone effectsMenopause: Health Impacts and Treatments

Cited by 15

Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer

Geisen, M. E., Tessmann, J. W., Kelson, C. O., He, D., Wang, C., Faisal, A. S. M., Beswick, E. J., Baca, Y., Rock, S., Kolesar, J. M., et al. (2026) · Neoplasia

Colorectal Cancer Treatments and StudiesCancer, Lipids, and Metabolism

Cited by 0